GB0108821D0 - Therapy - Google Patents

Therapy

Info

Publication number
GB0108821D0
GB0108821D0 GB0108821A GB0108821A GB0108821D0 GB 0108821 D0 GB0108821 D0 GB 0108821D0 GB 0108821 A GB0108821 A GB 0108821A GB 0108821 A GB0108821 A GB 0108821A GB 0108821 D0 GB0108821 D0 GB 0108821D0
Authority
GB
United Kingdom
Prior art keywords
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0108821A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bristol
Original Assignee
University of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bristol filed Critical University of Bristol
Priority to GB0108821A priority Critical patent/GB0108821D0/en
Publication of GB0108821D0 publication Critical patent/GB0108821D0/en
Priority to EP08016235A priority patent/EP2058332A1/en
Priority to PCT/EP2002/003808 priority patent/WO2002081508A2/en
Priority to AT02740446T priority patent/ATE408629T1/en
Priority to RU2003130636/15A priority patent/RU2318537C2/en
Priority to NZ528411A priority patent/NZ528411A/en
Priority to SK1221-2003A priority patent/SK12212003A3/en
Priority to IL15806002A priority patent/IL158060A0/en
Priority to PT02740446T priority patent/PT1379557E/en
Priority to CZ20032672A priority patent/CZ20032672A3/en
Priority to KR1020037012923A priority patent/KR100975042B1/en
Priority to KR1020087028908A priority patent/KR20080110687A/en
Priority to AU2002315271A priority patent/AU2002315271B2/en
Priority to CNB028074807A priority patent/CN1296386C/en
Priority to JP2002579494A priority patent/JP2005502593A/en
Priority to HU0400986A priority patent/HUP0400986A3/en
Priority to US10/474,071 priority patent/US20040146508A1/en
Priority to MXPA03009115A priority patent/MXPA03009115A/en
Priority to ES02740446T priority patent/ES2314067T3/en
Priority to BR0208656-5A priority patent/BR0208656A/en
Priority to CA002443405A priority patent/CA2443405A1/en
Priority to DE60228945T priority patent/DE60228945D1/en
Priority to PL02363029A priority patent/PL363029A1/en
Priority to EP02740446A priority patent/EP1379557B1/en
Priority to IL158060A priority patent/IL158060A/en
Priority to ZA200307401A priority patent/ZA200307401B/en
Priority to NO20034453A priority patent/NO20034453L/en
Priority to JP2008328042A priority patent/JP2009102367A/en
Priority to US12/378,454 priority patent/US20090274691A1/en
Ceased legal-status Critical Current

Links

GB0108821A 2001-04-06 2001-04-06 Therapy Ceased GB0108821D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GB0108821A GB0108821D0 (en) 2001-04-06 2001-04-06 Therapy
EP02740446A EP1379557B1 (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
JP2002579494A JP2005502593A (en) 2001-04-06 2002-04-05 Use of CD25 binding molecules in steroid resistant patients
US10/474,071 US20040146508A1 (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
HU0400986A HUP0400986A3 (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
RU2003130636/15A RU2318537C2 (en) 2001-04-06 2002-04-05 Application of cd25-binding molecules for treatment of steroid-resistant patients
PCT/EP2002/003808 WO2002081508A2 (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
SK1221-2003A SK12212003A3 (en) 2001-04-06 2002-04-05 Use of CD25 binding molecules in steroid-resistant patients
IL15806002A IL158060A0 (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
PT02740446T PT1379557E (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
CZ20032672A CZ20032672A3 (en) 2001-04-06 2002-04-05 Use of CD25 binding molecules in the prevention or treatment of some diseases in a steroid-resistant patient
KR1020037012923A KR100975042B1 (en) 2001-04-06 2002-04-05 Use of CD25 Binding Molecules in Steroid-Resistant Patients
KR1020087028908A KR20080110687A (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
MXPA03009115A MXPA03009115A (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients.
CNB028074807A CN1296386C (en) 2001-04-06 2002-04-05 Use of CD 25 binding molecules in steroid-resistant patients
EP08016235A EP2058332A1 (en) 2001-04-06 2002-04-05 Use of CD25 binding molecules in steroid-resistant patients
AT02740446T ATE408629T1 (en) 2001-04-06 2002-04-05 USE OF CD25-BINDING MOLECULES FOR PATIENTS WITH STEROID RESISTANCE
NZ528411A NZ528411A (en) 2001-04-06 2002-04-05 Use of CD25 binding molecules in steroid-resistant patients and improving the response to steroid therapy in steroid-sensitive patients
AU2002315271A AU2002315271B2 (en) 2001-04-06 2002-04-05 Use of CD25 binding molecules in steroid-resistant patients
ES02740446T ES2314067T3 (en) 2001-04-06 2002-04-05 USE OF CD 25 LINK MOLECULES IN STEROID RESISTANT PATIENTS.
BR0208656-5A BR0208656A (en) 2001-04-06 2002-04-05 Use of cd25 ligand molecules in steroid resistant patients
CA002443405A CA2443405A1 (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
DE60228945T DE60228945D1 (en) 2001-04-06 2002-04-05 USE OF CD25-BINDING MOLECULES FOR PATIENTS WITH STEROID RESISTANCE
PL02363029A PL363029A1 (en) 2001-04-06 2002-04-05 Use of cd25 binding molecules in steroid-resistant patients
IL158060A IL158060A (en) 2001-04-06 2003-09-22 Cd25 binding molecules for use in the prevention or treatment of diseases in steroid-resistant patients
ZA200307401A ZA200307401B (en) 2001-04-06 2003-09-23 Use of CD25 binding molecules in steroid-resistant patients.
NO20034453A NO20034453L (en) 2001-04-06 2003-10-03 Use of CD25-binding molecules in steroid-resistant patients
JP2008328042A JP2009102367A (en) 2001-04-06 2008-12-24 Use of cd25 binding molecule in steroid-resistant patient
US12/378,454 US20090274691A1 (en) 2001-04-06 2009-02-13 Use of CD25 binding molecules in steroid-resistant patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0108821A GB0108821D0 (en) 2001-04-06 2001-04-06 Therapy

Publications (1)

Publication Number Publication Date
GB0108821D0 true GB0108821D0 (en) 2001-05-30

Family

ID=9912495

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0108821A Ceased GB0108821D0 (en) 2001-04-06 2001-04-06 Therapy

Country Status (2)

Country Link
GB (1) GB0108821D0 (en)
ZA (1) ZA200307401B (en)

Also Published As

Publication number Publication date
ZA200307401B (en) 2004-04-21

Similar Documents

Publication Publication Date Title
EP1463438A4 (en) Endomural therapy
GB0119152D0 (en) Therapeutic agents
GB0126879D0 (en) Combination therapy
GB0118383D0 (en) Therapeutic methods
GB0113841D0 (en) Therapeutic agents
GB0120347D0 (en) Therapeutic agents
GB0117060D0 (en) Therapeutic agents
GB0114867D0 (en) Therapeutic agents
GB0108930D0 (en) Therapeutic agents
GB0113842D0 (en) Therapeutic agents
GB0113839D0 (en) Therapeutic agents
GB0111191D0 (en) Therapeutic agents
GB0101933D0 (en) Therapy
GB0108485D0 (en) Combination therapy
GB0122746D0 (en) Defibrillator
GB0113843D0 (en) Therapeutic agents
IL147696A0 (en) Combination therapy
GB0119803D0 (en) Therapeutic agents
GB0120345D0 (en) Therapeutic agents
GB0108982D0 (en) Therapeutic agents
GB0128122D0 (en) Therapeutic use
GB0119828D0 (en) Therapeutic agents
GB0108817D0 (en) Therapy
GB0108816D0 (en) Therapy
GB0108821D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)